Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma

Blood Cells, Molecules, and Diseases

Volumn 35, Issue 1, 2005, Pages 27-32

  Fracanzani, Anna Ludovica ^a   Fargion, Silvia ^a   Stazi, Maria Antonietta ^b   Valenti, Luca ^a   Amoroso, Pietro ^c   Cariani, Elisabetta ^d   Sangiovanni, Angelo ^e   Tommasini, Maurizio ^f   Rossini, Angelo ^d   Bertelli, Cristina ^a   Fatta, Erika ^a   Patriarca, Valeria ^b   Brescianini, Sonia ^b   Stroffolini, Tomaso ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

^d SPEDALI CIVILI   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

HBV infection; HCV infection; Hepatocellular carcinoma; HFE mutations

Indexed keywords

ALCOHOL; DNA; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HFE PROTEIN; IRON;

ADULT; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; FOLLOW UP; GENE INTERACTION; GENE MUTATION; GENETIC ASSOCIATION; GEOGRAPHIC DISTRIBUTION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INFECTION RISK; IRON METABOLISM; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; VIRUS DNA CELL DNA INTERACTION; VIRUS MUTATION; WILD TYPE;

ANTIBODIES, VIRAL; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS VIRUSES; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; LIVER CIRRHOSIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; RISK FACTORS; SEX FACTORS;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 21544436867     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2005.03.007     Document Type: Article

References (38)

1. T. Stroffolini, P. Andreone, A. Andriulli, A. Ascione, A. Craxi, and M. Chiaramonte Characteristics of hepatocellular carcinoma in Italy J. Hepatol. 29 1998 944 952
2. T. Stroffolini, M. Chiaramonte, C. Tiribelli, E. Villa, R.G. Simonetti, and M. Rapicetta Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study in Italy J. Hepatol. 16 1992 360 363
3. M. Chiaramonte, T. Stroffolini, A. Vian, M.A. Stazi, A. Floreani, and U. Lorenzoni Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis Cancer 85 15 1999 2132 2137
4. R.G. Simonetti, C. Camma, F. Fiorello, M. Cottone, M. Rapicetta, and L. Marino Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study Ann. Intern. Med. 116 15 1992 97 102
5. E.D. Weinberg The role of iron in cancer Eur. J. Cancer Prev. 5 1996 19 36
6. Y. Deugnier, B. Turlin, and O. Loreal Iron and neoplasia J. Hepatol. 28 1998 21 25
7. A.L. Fracanzani, D. Conte, M. Fraquelli, E. Taioli, M. Mattioli, A. Losco, and S. Fargion Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease Hepatology 33 2001 647 651
8. B. Turlin, F. Juguet, R. Moirand, D. Le Quilleuc, O. Loreal, J.P. Campion, and B. Launois Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver Hepatology 22 1995 446 450
9. E. Mandishona, A.P. MacPhail, V.R. Gordeux, M.A. Kedda, A.C. Paterson, and T.A. Rouault Dietary iron overload as a risk for hepatocellular carcinoma in black Africans Hepatology 27 1998 1563 1566
10. J.N. Feder, A. Gnirke, W. Thomas, Z. Tsuchihashi, D.A. Ruddy, and A. Basava A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis Nat. Genet. 13 1996 399 408
11. H.L. Bonkovsky, B.F. Banner, and A.L. Rothman Iron and chronic viral hepatitis Hepatology 25 1997 759 768
12. M. Pirisi, P. Toniutto, A. Uzzau, C. Fabris, C. Avellini, and C. Scott Carriage of HFE mutations and outcome of surgical resection for hepatocellular carcinoma in cirrhotic patients Cancer 89 2000 297 302
13. J.K. Olynyk, D.J. Cullen, S. Aquilia, E. Rossi, L. Summerville, and L.W. Powell A population-based study of the clinical expression of the hemochromatosis gene N. Engl. J. Med. 341 1999 718 724
14. E. Beutler, V.J. Felitti, J.A. Koziol, N.J. Ho, and T. Gelbart Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA Lancet 359 9302 2002 211 218
15. R.V. Andersen, A. Tybjaerg-Hansen, M. Appleyard, and H. Birgens Nordestgaard, Hemochromatosis mutations in the general population: iron overload progression rate Blood 15 103(8) 2004 2914 2919
16. V. Chambers, L. Sutherland, K. Palmer, A. Dalton, A.S. Rigby, and R. Sokol Haemochromatosis-associated HFE genotypes in English blood donors: age-related frequency and biochemical expression J. Hepatol. 39 6 2003 925 931
17. E. Beutler The significance of the 187G (H63D) mutation in hemochromatosis Am. J. Hum. Genet. 61 1997 762 764
18. P.A. Gochee, L.W. Powell, D.J. Cullen, D. Du Sart, E. Rossi, and J.K. Olynyk A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutations Gastroenterology 122 2002 646 651
19. R. Moirand, A.M. Jonauolle, P. Brissot, J.Y. Le Gall, V. David, and Y. Deugnier Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overloaded patients and relatives Gastroenterology 116 1999 372 377
20. S. Fargion, M.A. Stazi, A.L. Fracanzani, M. Mattioli, M. Sampietro, and D. Tavazzi Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma Blood Cells, Mol. Dis. 27 2001 505 511
21. J. Bruix, M. Sherman, J.M. Llovet, M. Beaugrand, R. Lencioni, and A.K. Burroughs Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference J. Hepatol. 35 2001 421 430
22. U. Becker, A. Deis, T.I. Sorensen, M. Gronbaek, K. Borch-Johnsen, and C.F. Muller Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study Hepatology 23 1996 (May) 1025 1029
23. P.G. Scheuer, R. Williams, and A.R. Muir Hepatic pathology in relatives of patients with hemochromatosis J. Pathol. Bacteriol. 84 1962 53 64
24. M. Sampietro, A. Piperno, L. Lupica, C. Arosio, A. Vergani, and N. Corbetta High prevalence of the His63Asp HFE mutations in Italian patients with porphyria cutanea tarda Hepatology 27 1998 181 184
25. W.W. Piegorsch, C.R. Weinberg, and J.A. Taylor Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies Stat. Med. 13 2 1994 (Jan 30) 153 162
26. M.J. Khoury, and W.D. Flanders Non traditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am. J. Epidemiol. 144 1996 207 213
27. M. Elmberg, R. Hultcrantz, A. Ekbom, L. Brandt, S. Olsson, and R. Olsson Cancer risk in patients with hereditary hemochromatosis and their first-degree realtives Gastroenterology 125 2003 1733 1741
28. E. Cauza, M. Peck-Radosavljevic, H. Ulrich-Pur, C. Datz, M. Gschwantler, and M. Schoniger-Hekele Mutations of the HFE gene in patients with hepatocellular carcinoma Am. J. Gastroenterol. 98 2003 442 447
29. V. Boige, L. Castera, N. de Roux, N. Ganne-Carrie, B. Ducot, and G. Pelletier Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis Gut 52 2003 1178 1181
30. S. Fargion, A.L. Fracanzani, A. Piperno, M. Braga, R. D'Alba, G. Ronchi, and G. Fiorelli Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis Hepatology 20 1994 1426 1431
31. A.M. Di Bisceglie, C.A. Axiotis, J.H. Hoofnagle, and B.R. Bacon Measurements of iron status in patients with chronic hepatitis Gastroenterology 102 1992 2108 2113
32. A. Piperno, R. D'Alba, S. Fargion, L. Roffi, M. Sampietro, and S. Parma Liver iron concentration in chronic viral hepatitis: a study of 98 patients Eur. J. Gastroenterol. Hepatol. 7 1995 1203 1208
33. A. Pietrangelo Hemochromatosis gene modifies course of hepatitis C viral infection Gastroenterology 124 2003 1509 1523
34. B.Y. Tung, M.J. Edmond, M.P. Bronner, S.D. Raaka, S.J. Cotler, and K.V. Kowdey Hepatitis C iron status, disease severity: relationship with HFE mutations Gastroenterology 124 2003 318 326
35. A. Pietrangelo Metals, oxidative stress, hepatic fibrogenesis Semin. Liver Dis. 16 1996 13 30
36. L.E. Rikans, and K.R. Hornbrook Lipid peroxidation, antioxidant protection and aging Biochim. Biophys. Acta 1362 1997 116 127
37. Y. Sobao, H. Tomiyama, K. Sugi, M. Tokunaga, T. Ueno, and S. Saito The role of hepatitis B virus-specific memory CD8 cells in the control of viral replication J. Hepatol. 36 2002 105 115
38. A. Lopez-Vazquez, L. Rodrigo, A. Mina-Blanco, J. Martinez-Borra, D. Fuentes, and M. Rodriguez Extended human leukocyte antigen haplotype EH18.1 influences progression to hepatocellular carcinoma in patients with chronic C virus infections J. Infect. Dis. 189 2004 957 963